Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer

Figure 4

ROC curve analysis of potential serum biomarker and other tumor marker (CEA, CYFRA21-1) levels for differentiating the control group from the PRLC group (low levels of biomarkers in PRLC).